Last Updated: 09 Nov 2024
Executive Summary
Natural Alternatives International (NAII) is a nutritional supplements company with a market capitalization of $28.2 million. The company has been facing financial challenges, with negative earnings and margins. Despite a recent uptick in quarterly earnings growth, the company's overall financial performance remains weak. The stock price is currently trading at $4.55, below its 52-week high of $7.37.
Company Overview
NAII formulates, manufactures, and markets nutritional supplements in the United States and internationally. The company's products are sold through a variety of channels, including retail stores, healthcare practitioners, and online retailers. NAII has been in business for over 20 years and has a strong brand presence in the nutritional supplements industry.
Fundamental Analysis
NAII's financial performance has been weak in recent years. The company has reported negative earnings per share (EPS) and profit margins for the past several quarters. The company's revenue growth has also been slow, with quarterly revenue growth of only 0.265% year-over-year.
NAII's financial ratios are also weak. The company has a negative return on assets (ROA) and return on equity (ROE). The company's price-to-sales ratio is also high at 0.248, indicating that the stock is overvalued relative to its sales.
Technical Analysis
NAII's stock price has been trending down in recent months. The stock is currently trading below its 50-day and 200-day moving averages. The stock's relative strength index (RSI) is also below 50, indicating that the stock is oversold.
Short Term Outlook
NAII's short-term outlook is negative. The company's financial performance is weak and the stock price is trending down. The stock is likely to continue to decline in the short term.
Long Term Outlook
NAII's long-term outlook is also negative. The company's financial challenges are likely to continue in the long term. The stock is likely to remain undervalued until the company can improve its financial performance.
Analyst Recommendations
Analysts are negative on NAII. No analysts have a buy rating on the stock. The consensus analyst rating is a hold.
